Nuwellis (NUWE) Other Non-Current Assets (2015 - 2026)
Nuwellis' (NUWE) quarterly Other Non-Current Assets came in at $599000.0 in Q2 2026, up 2752.38% on a YoY basis from $21000.0 in Q2 2025, and up 42.62% quarter-over-quarter from $420000.0 in Q1 2026.
Analysis
Nuwellis (NUWE) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Other Non-Current Assets for 12 consecutive years, with $599000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 2752.38% year-over-year to $599000.0; the trailing twelve-month figure through Jun 2026 stood at $599000.0 (up 2752.38% YoY), and the FY2025 full-year result was $271000.0, up 1190.48% from the prior year.
- Other Non-Current Assets advanced to $599000.0 in Q2 2026 per NUWE's latest filing, from $420000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $599000.0 in Q2 2026 and bottomed at $21000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $126888.9 across 5 years, with a median of $113000.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets sank 82.5% in 2024, then surged 2752.38% in 2026.
- Over 5 years, Other Non-Current Assets stood at $21000.0 in 2022, then soared by 471.43% to $120000.0 in 2023, then tumbled by 82.5% to $21000.0 in 2024, then soared by 1190.48% to $271000.0 in 2025, then soared by 121.03% to $599000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $599000.0, $420000.0, and $271000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 599,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 599,000.00 |
| Mar 31, 2026 | 420,000.00 |
| Dec 31, 2025 | 271,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 120,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Sep 30, 2023 | 120,000.00 |
| Jun 30, 2023 | 120,000.00 |
| Mar 31, 2023 | 106,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 21,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 21,000.00 |